Yong Yu

Serum pleiotrophin could be an early indicator for diagnosis and prognosis of non-small cell lung cancer.

M. Shi, Z. Du, C. Ji, 2015, Asian Pacific journal of cancer prevention : APJCP.

Non-platinum regimens of gemcitabine plus docetaxel versus platinum-based regimens in first-line treatment of advanced non-small cell lung cancer: a meta-analysis on 9 randomized controlled trials

M. Shi, Z. Du, Yong Yu, 2012, Cancer Chemotherapy and Pharmacology.

Beclin 1 and p62 expression in non-small cell lung cancer: relation with malignant behaviors and clinical outcome.

M. Shi, Xifeng Wang, Z. Du, 2015, International journal of clinical and experimental pathology.

Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable Stage I/II non-small-cell lung cancer.

Ping Li, Joe Y. Chang, Ping Li, 2006, International journal of radiation oncology, biology, physics.

Multicenter study of diagnostic procedures, genetic aberration analysis, and first‐line treatment of lung cancer in Jiangsu Province, China

Jian Feng, Liming Cai, M. Shi, 2018, Thoracic cancer.

The molecular mechanism of long non-coding ribonucleic acid (lncRNA) RUNX1-IT1 promotes the proliferation and stemness of lung cancer cells

Jian-qiu Wu, Yufei Liu, Yong Yu, 2021, Translational cancer research.

[Construction of siRNA lentiviral expressing vector targeting pleiotrophin gene and its impact on growth and apoptosis in H446 cells of human small cell lung cancer].

M. Shi, Yong Yu, Xun Xu, 2010, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases.